The authors of the present invention have found, produced and characterized a new fusion protein obtained by linking a targeting antibody fragment to E. coli type II L-Asparaginase (EcAII).
An antibody drug conjugate based on asparaginase
Maristella Maggi;PESSINO, GRETA;Claudia Scotti
2018-01-01
Abstract
The authors of the present invention have found, produced and characterized a new fusion protein obtained by linking a targeting antibody fragment to E. coli type II L-Asparaginase (EcAII).File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
